2-Methyl-6-{[(4-nitro-3-trifluoromethyl-phenyl)-prop-2-ynyl-amino]-methyl}-3H-quinazolin-4-one

ID: ALA171180

PubChem CID: 135503923

Max Phase: Preclinical

Molecular Formula: C20H15F3N4O3

Molecular Weight: 416.36

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C#CCN(Cc1ccc2nc(C)nc(O)c2c1)c1ccc([N+](=O)[O-])c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C20H15F3N4O3/c1-3-8-26(14-5-7-18(27(29)30)16(10-14)20(21,22)23)11-13-4-6-17-15(9-13)19(28)25-12(2)24-17/h1,4-7,9-10H,8,11H2,2H3,(H,24,25,28)

Standard InChI Key:  PAGXQGCQFLMONT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    6.7542   -3.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0917   -2.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8042   -2.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9667   -2.8917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3792   -2.9792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0917   -4.2167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1417   -2.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1875   -4.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8042   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3792   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9292   -3.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -2.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6667   -2.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2625   -1.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7167   -2.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6541   -1.0379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5167   -2.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4042   -3.5917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3625   -2.1625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0917   -1.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9542   -2.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2292   -2.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8875   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5167   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5917   -5.0625    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.7917   -5.0750    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.0125   -4.3292    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.8625   -2.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3458   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3 17  2  0
  4  7  1  0
  5  2  2  0
  6  9  1  0
  7  1  2  0
  8  1  1  0
  9 24  2  0
 10  6  2  0
 11  1  1  0
 12 11  2  0
 13 12  1  0
 14 28  1  0
 15  7  1  0
 16 14  3  0
 17 22  1  0
 18  4  1  0
 19  4  2  0
 20  2  1  0
 21 13  1  0
 22 21  1  0
 23 12  1  0
 24 29  1  0
 25  8  1  0
 26  8  1  0
 27  8  1  0
 28 13  1  0
 29 22  2  0
 30 10  1  0
 15 23  2  0
  3  9  1  0
  5 10  1  0
M  CHG  2   4   1  18  -1
M  END

Alternative Forms

  1. Parent:

    ALA171180

    ---

Associated Targets(Human)

TYMS Tclin Thymidylate synthase (1651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

thyA Thymidylate synthase (595 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.36Molecular Weight (Monoisotopic): 416.1096AlogP: 4.21#Rotatable Bonds: 5
Polar Surface Area: 92.39Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.82CX Basic pKa: 1.82CX LogP: 5.29CX LogD: 5.29
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.38Np Likeness Score: -1.69

References

1. Jones TR, Varney MD, Webber SE, Lewis KK, Marzoni GP, Palmer CL, Kathardekar V, Welsh KM, Webber S, Matthews DA, Appelt K, Smith WW, Janson CA, Villafranca JE, Bacquet RJ, Howland EF, Booth CL, Herrmann SM, Ward RW, White J, Moomaw EW, Bartlett CA, Morse CA..  (1996)  Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.,  39  (4): [PMID:8632414] [10.1021/jm9502652]

Source